rs10801935
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | normal | |
(A;C) | normal | |
(C;C) | 1.6 | 0.3x decreased risk of breast cancer |
Reference | GRCh38 38.1/141 |
Chromosome | 1 |
Position | 117179265 |
Gene | VTCN1 |
is a | snp |
is | mentioned by |
dbSNP | rs10801935 |
dbSNP (classic) | rs10801935 |
ClinGen | rs10801935 |
ebi | rs10801935 |
HLI | rs10801935 |
Exac | rs10801935 |
Gnomad | rs10801935 |
Varsome | rs10801935 |
LitVar | rs10801935 |
Map | rs10801935 |
PheGenI | rs10801935 |
Biobank | rs10801935 |
1000 genomes | rs10801935 |
hgdp | rs10801935 |
ensembl | rs10801935 |
geneview | rs10801935 |
scholar | rs10801935 |
rs10801935 | |
pharmgkb | rs10801935 |
gwascentral | rs10801935 |
openSNP | rs10801935 |
23andMe | rs10801935 |
SNPshot | rs10801935 |
SNPdbe | rs10801935 |
MSV3d | rs10801935 |
GWAS Ctlg | rs10801935 |
GMAF | 0.3838 |
Max Magnitude | 1.6 |
? | (A;A) (A;C) (C;C) | 28 |
---|---|---|
|
rs10801935 is a SNP in the V-set domain containing T cell activation inhibitor 1 VTCN1 gene, which is also known as B7-H4.
A study of 500 Chinese Han women with breast cancer (and an equal number of matched controls) concluded that the rs10801935(C;C) genotype showed a significantly decreased risk of breast cancer (odds ratio 0.328, CI: 0.145-0.739).[PMID 19903360]
[PMID 24125968] An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer